Document
IPR2019-00451, No. 2028-152 Exhibit - ¿¿¿Intranasal Technology, Inc Licenses Aegis Therapeutics IntravailDrug Delivery Technology¿¿¿ Business Wire April 13, 2005 (P.T.A.B. Mar. 10, 2020)
Cite Document
IPR2019-00451, No. 2028-152 Exhibit - ¿¿¿Intranasal Technology, Inc Licenses Aegis Therapeutics IntravailDrug Delivery Technology¿¿¿ Business Wire April 13, 2005 (P.T.A.B. Mar. 10, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1120-124 Exhibit - Davis GA, Rudy AC, Archer SM, Wermeling DP, McNamara PJ, Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencin...
Cite Document
IPR2019-00451, No. 1120-124 Exhibit - Davis GA, Rudy AC, Archer SM, Wermeling DP, McNamara PJ, Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencing vasomotor rhin
+ More Snippets
Document
IPR2019-00451, No. 1110-114 Exhibit - Wolfe T, Macfarlane T Intranasal midazolam therapy for pediatric status epilepticus Am J Emerg Med 2006 24 343 346 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1110-114 Exhibit - Wolfe T, Macfarlane T Intranasal midazolam therapy for pediatric status epilepticus Am J Emerg Med 2006 24 343 346 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1004-12 Exhibit - Part 8 ¿¿¿ Pages 2451 2681 File History for ¿¿¿546 Patent, Ser No 13495,942 ¿¿¿546 FH (P.T.A.B. Jan. 29, 2019)
Cite Document
IPR2019-00451, No. 1004-12 Exhibit - Part 8 ¿¿¿ Pages 2451 2681 File History for ¿¿¿546 Patent, Ser No 13495,942 ¿¿¿546 FH (P.T.A.B. Jan. 29, 2019)
+ More Snippets
Document
IPR2019-00451, No. 1019-35 Exhibit - Ueda et al, US Patent No 4,657,901, Pharmaceutical Composition, issued April 14, 1987 Ueda (P.T.A.B. Jan. 29, 2019)
Cite Document
IPR2019-00451, No. 1019-35 Exhibit - Ueda et al, US Patent No 4,657,901, Pharmaceutical Composition, issued April 14, 1987 Ueda (P.T.A.B. Jan. 29, 2019)
+ More Snippets
Document
IPR2019-00451, No. 1004-11 Exhibit - Part 7 ¿¿¿ Pages 2101 2450 File History for ¿¿¿546 Patent, Ser No 13495,942 ¿¿¿546 FH (P.T.A.B. Jan. 29, 2019)
Cite Document
IPR2019-00451, No. 1004-11 Exhibit - Part 7 ¿¿¿ Pages 2101 2450 File History for ¿¿¿546 Patent, Ser No 13495,942 ¿¿¿546 FH (P.T.A.B. Jan. 29, 2019)
+ More Snippets
Document
IPR2019-00451, No. 1007-17 Exhibit - Part 3 ¿¿¿ Pages 801 1200 File History for Non Provisional Patent Application Serial No 12413,439, filed March 27, 2009 ¿¿¿439 FH (P.T.A.B. Jan. 29, 2019)
Cite Document
IPR2019-00451, No. 1007-17 Exhibit - Part 3 ¿¿¿ Pages 801 1200 File History for Non Provisional Patent Application Serial No 12413,439, filed March 27, 2009 ¿¿¿439 FH (P.T.A.B. Jan. 29, 2019)
+ More Snippets
Document
IPR2019-00451, No. 1112-116 Exhibit - Prasad K, Krishman P, Al Roomi K, et al, Anticonvulsant therapy for status epilepticus Br J Clin Pharmacol 2007 63 640 647 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1112-116 Exhibit - Prasad K, Krishman P, Al Roomi K, et al, Anticonvulsant therapy for status epilepticus Br J Clin Pharmacol 2007 63 640 647 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 2016-83 Exhibit - D Terry et al, ¿¿¿Acceptance of the Use of Diazepam Rectal Gel in School and Day Care Settings,¿¿¿ Journal of Child Neurology 221135 1138 2007 (P.T.A.B. ...
Cite Document
IPR2019-00451, No. 2016-83 Exhibit - D Terry et al, ¿¿¿Acceptance of the Use of Diazepam Rectal Gel in School and Day Care Settings,¿¿¿ Journal of Child Neurology 221135 1138 2007 (P.T.A.B. Nov. 5, 20
+ More Snippets
Document
IPR2019-00451, No. 1107-111 Exhibit - Pang T, Hirsch L Treatment of convulsive and nonconvulsive status epilepticus Cur Treat Options Neurol 2005 7 247 259 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1107-111 Exhibit - Pang T, Hirsch L Treatment of convulsive and nonconvulsive status epilepticus Cur Treat Options Neurol 2005 7 247 259 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1150-149 Exhibit - Declaration of Daniel P Wermeling, PharmD (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1150-149 Exhibit - Declaration of Daniel P Wermeling, PharmD (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1103-107 Exhibit - Wang HC, Chang WN, Chang HW, et al Factors predictive of outcome in posttraumatic seizures J Trauma 2008 64 883 888 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1103-107 Exhibit - Wang HC, Chang WN, Chang HW, et al Factors predictive of outcome in posttraumatic seizures J Trauma 2008 64 883 888 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1148-147 Exhibit - FDA GUIDANCE FOR INDUSTRY 1999, Applications Covered by Section 505b2, httpswwwfdagovmedia72419download (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1148-147 Exhibit - FDA GUIDANCE FOR INDUSTRY 1999, Applications Covered by Section 505b2, httpswwwfdagovmedia72419download (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1116-120 Exhibit - Illum L Is nose to brain transport of drugs a reality JPP 2004 56 3 17 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1116-120 Exhibit - Illum L Is nose to brain transport of drugs a reality JPP 2004 56 3 17 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 2018-85 Exhibit - ¿¿¿UCB announces NAYZILAM¿¿ midazolam nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in peop...
Cite Document
IPR2019-00451, No. 2018-85 Exhibit - ¿¿¿UCB announces NAYZILAM¿¿ midazolam nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living wit
+ More Snippets